Research Square·26 AugAn Open-Label Single-Arm Phase I/IIa Study to Evaluate the Safety of Human Allogeneic Bone-Marrow-Derived Mesenchymal Stromal Cell Product StromaForte ® for the Treatment of Knee OsteoarthritisPreprint: trial in peopleInterventionsPaper